Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: "As a matter of course, stories about the increased use of drugs should report the drugs' prices. A change in guidelines based on the study would increase the number of patients eligible for treatment by several hundred thousand in the US. The annualized cost of drug treatment is $12,000-$24,000 depending on the regimen, leading to potential new expenditures of $24 to $48 billion. While there are significant offsets, the potential for this level of additional costs should have been included in the story The story states that delaying treatment ""nearly doubles the risk of dying over the next several years"" and yields a ""70 percent improvement in survival."" This reporting is vague. The story should have compared absolute risks, not relative risks. See our primer on this issue. The story should have included the time span studied. These numbers should have stated the two death rates directly so readers can understand the magnitude of the benefitwhether the risk of death went from [say] 2 percent to 1 percent or from 30 percent to 15 percent. The story places the recommended treatment of earlier drug intervention in the context of the treatments' known side effects, which can be very serious. The story should have described the severity of those side effects. We give this a satisfactory score, but barely. The report is based on a study presented at a major medical meeting. The story should have mentioned the fact that it has not been published or peer-reviewed. It should also have pointed out that it was a retrospective cohort study, which is considered to be less conclusive than prospective, double-blind studies. It should also have pointed out, as the NIH press release does, that a clinical trial is needed to validate the results in a way that would call for changing the current guidelines. These failures to provide caveats and context earn the story an ""unsatisfactory"" rating under this criterion. The story does not exaggerate the gravity or prevalance of AIDS. The story quotes Anthony Fauci, one of the best-known and -respected experts in the field of HIV/AIDS. The story also quotes the study's lead investigator, and the author of AIDS treatment guidelines. That source's link to companies that make AIDS drugs is properly noted. The story also quotes an independent clinician familiar with the guidelines and the current research. The story plainly compares the current guidelines with the regimen tested. The story explains that the drug combinations used by AIDS patients have been widely used since the mid-1990s. No claims are made for the novelty of the drug treatment. The recommendation to treat earlier is presented not as novel, but as a plan under consideration and study for quite some time. The story does not draw excessively on the NIH press release." Claim: AIDS treatment should be started sooner, study says
"This is a Columbus Dispatch version of a story reported by the Associated Press. Since the Columbus paper changed the original article substantially, we send our comments to the Columbus paper. Taking the big view, this story about the benefits of starting the standard multi-drug AIDS treatment sooner than current guidelines suggest accomplishes its mission. It fairly describes important new research that verifies earlier work suggesting the same thing. It says, correctly, that the continuing research could drive changes in treatment. The story is well-sourced and provides a lucid description of the disease process and detailed definition of ""early"" treatment. Having said that, the report falls short of two key best practices: It fails to quantify the benefits of early treatment in a meaningful way. It uses ""relative risk"" [a percent reduction in mortality] instead of ""absolute risk"" [which would allow readers to understand the gravity of the risk and the size of the benefit. It fails to describe the limitations of the study with caveats and context. If the story had mentioned those limitations, its predictions of imminent clinical use and eventual changes to the guidelines would have been properly tempered. As presented, the story fails to check the sources' consistent enthusiasm with journalistic disinterest. Given the credibility of the study, the opinions of multiple high-quality sources and the previous research record, the predictions seem justifiable. But the history of AIDS science, treatment and politics recommends a bit more reporting distance and care."

Paragraph: An asthma sufferer wears a paper face mask as she is attended by nurses in this undated file image. REUTERS/Jason Reed The findings were published in the journal Lancet together with two other studies, which found that runny noses and wheezing early on in life may be strong predictors of asthma. In the first study, researchers pored through data provided by parents of more than 205,000 children and found paracetamol use in the first year of life was associated with a 46 percent higher risk of asthma by the time the children were 6 or 7 compared to those never exposed to the drug. Known as acetaminophen in the United States, where it is widely sold under the brand Tylenol, it is used to relieve fever, minor aches and pain, and is used in a liquid suspension for children. Medium use of paracetamol in the past 12 months increased asthma risk by 61 percent, while high dosages of once a month or more in the past year raised the risk by over three times. Medium use was defined as once per year or more, but less than once a month. Suspicions of a possible link between paracetamol and asthma emerged in recent years when experts observed an increased use of the drug to a simultaneous rise in asthma prevalence worldwide. One theory is that paracetamol reduces antioxidants in the body. Some experts think antioxidants, which stop unstable molecules known as free radicals from doing too much damage, can lower the risk of cancer, heart disease and other ailments. "Paracetamol can reduce antioxidant levels and ... that can give oxidative stress in the lungs and cause asthma," one of the researchers, Richard Beasley at the Medical Research Institute of New Zealand, told Reuters in a telephone interview. As with asthma, monthly use of paracetamol doubled the risk of eczema and trebled that of rhinoconjunctivitis repetitive sneezing, rhinorrhea, nasal congestion and hay fever by the time children were 6 or 7, the study found. However, the researchers stressed paracetamol should remain the preferred drug to relieve pain and fever in children because its alternative, aspirin, was linked to the risk of Reye's syndrome, a rare but serious complication in children. "The findings do lend support to the current guidelines of the World Health Organization, which recommend that paracetamol should not be used routinely, but should be reserved for children with a high fever (38.5 Celsius or above)," they wrote. Another study in The Lancet found that rhinitis, or hay fever and other allergic reactions causing a runny nose, was a strong predictor of asthma that develops in adulthood. Researchers monitored 6,461 people in 14 countries who were free of asthma at the start of study for more than 8 years. Those who suffered rhinitis and were allergic to an assortment of agents like house dust mites, cat, grass and birch were 3.5 times more likely to develop asthma later on compared to those who suffered no allergies nor rhinitis. The third study in Arizona in the United States found wheezing early in life may be an ominous sign of asthma developing in adulthood. Researchers pored through data on 849 people going back 22 years to the time they were babies. Of 181 cases of active asthma, 49 were newly diagnosed, of which 35 were women. "In over 70 percent of people with current asthma and 63 percent of those with newly diagnosed asthma at age 22 years, episodes of wheezing had happened in the first three years of life or were reported by parents at age six years," wrote the researchers at the Arizona Respiratory Center. In an accompanying comment, Suzanne Lau of Charite University Medicine in Germany, wrote: "These findings identify a population at risk of chronic obstructive airway disease in early adulthood, and they already showed a predisposition during preschool years." Lau was not involved in the study. Claim: Paracetamol use may raise asthma risk in children.
Infants who have been given the common pain reliever paracetamol may have a higher risk of developing asthma and eczema by the time they are 6 or 7, a large study covering children in 31 countries has found.

Paragraph: The government had gone to the High Court to extend an April 24 deadline to submit its plan to improve air quality and comply with nitrogen dioxide limits set by the European Union (EU). But the court ruled on Thursday against any extension, ordering a draft plan to be submitted by May 9 and a full report by July 31, British media reported. The government is obliged to draw up a new plan after the High Court ruled in November that a calculation of future vehicle emissions was too optimistic. It was not immediately clear whether the government would appeal Thursday's ruling. The Department for Environment, Food and Rural Affairs said it was considering the judgment. Concern over air quality has grown since the Volkswagen (VOWG_p.DE) emissions scandal broke and reports that real-world emissions exceed those recorded during laboratory tests have put pollution high on the political agenda. "Air pollution is an election issue with or without publication of this plan, and we clearly need robust commitments from all parties on tackling the UK's toxic air," said Areeba Hamid, a clean air campaigner at environmental group Greenpeace. Nitrogen oxides reduce air quality and EU member states have been flouting limits on a range of pollutants associated with respiratory and other illnesses and more than 400,000 premature deaths per year, according to European Commission data. Under the EU's Air Quality Directive, member states were supposed to comply with nitrogen dioxide limits in 2010 - or by 2015 if they delivered plans to deal with high levels of the gas, which is produced mainly by diesel engines. Claim: Britain loses case to delay submission of air pollution plan.
The British government has failed in a legal bid to delay the publication of its plan to tackle air pollution until after the general election on June 8.